|Bid||171.39 x 900|
|Ask||171.47 x 800|
|Day's Range||170.49 - 175.25|
|52 Week Range||118.64 - 175.25|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||51.31|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 21, 2012|
|1y Target Est||N/A|
Masimo Corporation (NASDAQ: MASI) today announced select preliminary results for the full-year ended December 28, 2019 and provided estimates for its full-year 2020 financial guidance.
Masimo and NantHealth announced the signing of a definitive agreement under which Masimo will acquire the Connected Care assets from NantHealth.
Masimo RD SET® sensors for neonatal patients have received FDA clearance for improved SpO2 accuracy specifications.
Masimo and Dräger are expanding their licensing agreement to add Masimo SedLine®, O3®, and NomoLine® to Dräger patient monitors.
A multicenter study evaluated the trend accuracy of three hemoglobin monitoring methods, including noninvasive Masimo SpHb® and two invasive methods.
Masimo today announced that its management is scheduled to present at the Evercore ISI 2nd Annual HealthCONx Conference at the Four Seasons Boston Hotel on Thursday, December 5, 2019 at 11:00 a.m.
Masimo today announced that its management is scheduled to present at the Piper Jaffray 31st Annual Healthcare Conference at the Lotte New York Palace Hotel on Wednesday, December 4, 2019 at 9:30 a.m.
Masimo announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers at Nippon Medical School in Tokyo, Japan u
Masimo today announced that its management is scheduled to present at the Stifel 2019 Healthcare Conference at the Lotte New York Palace Hotel on Tuesday, November 19, 2019 at 10:55 a.m.
Radius Capnography with Bluetooth® Connectivity Seamlessly Integrates Tetherless Mainstream Capnography on Root
Masimo announced today the findings of an abstract recently presented at the American Society of Anesthesiologists 2019 Annual Meeting. In this independent study, researchers at Fukuoka University in Japan evaluated whether using Masimo SpHb® could help avoid postoperative anemia and inappropriate blood transfusion in patients undergoing total hip arthroplasty and total knee arthroplasty .1 SpHb, noninvasive, ...